NCT00483132已完成3 期
Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III
French Innovative Leukemia Organisation2 个研究点 分布在 1 个国家目标入组 232 人开始时间: 1994年9月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 232
- 试验地点
- 2
- 主要终点
- overall survival
研究概览
简要总结
Improved outcome of high risk lymphoblastic leukemia (ALL) with laite high dose therapy.
High dose versus conventional therapy for adult low risk T-ALL and Lymphoblastic lymphoma (LBL).
详细描述
Comparison between two autograf therapeutic strategies in high risk patients Ramdomised comparison between maintenance treatment with or not interferon alpha 2 a
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 15 Years 至 65 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •ALL high risk or low risk or lymphoblastic lymphoma
- •age 15-55 years old
- •informed consent signed
排除标准
- •patients previously treated with a chemotherapy or alpha-interferon
- •ALL 3 (burkitt like)
结局指标
主要结局
overall survival
时间窗: time to death
次要结局
- Efficacy of study treatments(time to end of treatment)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
2 期
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in KoreaAcute Lymphoblastic Leukemia, PediatricNCT06257394Hyoung Jin Kang74
已完成
2 期
High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell LymphomaB-Cell LymphomaNCT00965289Nantes University Hospital42
Unknown
2 期
Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in ChildrenChildAcute Lymphoblastic LeukemiaNCT02339350The Korean Society of Pediatric Hematology Oncology110
Unknown
不适用
Hyper-CVAD Treatment in Lymphoblastic LymphomaLymphoblastic LymphomaNCT01813344Ajou University School of Medicine50
已完成
4 期
Treatment of High Risk Adult Acute Lymphoblastic LeukemiaAcute Lymphoblastic LeukemiaNCT00853008PETHEMA Foundation100